Clinical trial
Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating…
NCT00238420 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00238420 |
|---|---|
| Title | Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer |
| Official title | A Phase I/II Trial of a Combination of Paclitaxel and Trastuzumab With Daily Irradiation or Paclitaxel Alone With Daily Irradiation Following Transurethral Surgery for Non-Cystectomy Candidates With Muscle-Invasive Bladder Cancer |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Collaborators | Radiation Therapy Oncology Group |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Bladder Urothelial Carcinoma, Stage I Bladder Cancer AJCC v6 and v7, Stage II Bladder Cancer AJCC v6 and v7, Stage III Bladder Cancer AJCC v6 and v7 |
| Intervention type | Biological, Drug, Radiation |
| Interventions | Paclitaxel, Radiation Therapy, Trastuzumab |
| Enrollment | 70 |
| Start date | Jul 26, 2005 |
| Primary completion | Feb 5, 2014 |
| Completion | May 20, 2022 |
| First posted | Oct 13, 2005 |
| Last update posted | Jul 19, 2022 |
| Countries | Canada, United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: